Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals.
about
Glutathione conjugation of busulfan produces a hydroxyl radical-trapping dehydroalanine metabolitePirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapyNintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosisPirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-AnalysisEfficacy and safety of pirfenidone for idiopathic pulmonary fibrosisPirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium.A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin BDouble-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.Pirfenidone treatment of idiopathic pulmonary fibrosis.The multifaceted role of pirfenidone and its novel targets.Pirfenidone: an anti-fibrotic therapy for progressive kidney disease.The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial.Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatmentProtective effect of Curcuma longa L. extract on CCl4-induced acute hepatic stressEmerging drugs for idiopathic pulmonary fibrosis.Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapyLung extracellular matrix and redox regulationOxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease.Pirfenidone is renoprotective in diabetic kidney disease.Alveolar macrophage dysregulation in Hermansky-Pudlak syndrome type 1.Pirfenidone: in idiopathic pulmonary fibrosis.Pirfenidone: a review of its use in idiopathic pulmonary fibrosis.Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.Pirfenidone for the treatment of idiopathic pulmonary fibrosis.Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: a case-control study.Pirfenidone treatment in idiopathic pulmonary fibrosis: A Saudi experienceA double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis.Pirfenidone attenuates ischaemia-reperfusion injury in the rat small intestine.Open-label study of pirfenidone in patients with progressive forms of multiple sclerosis.Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats.Pirfenidone ameliorates concanavalin A-induced hepatitis in mice via modulation of reactive oxygen species/nuclear factor kappa B signalling pathways.Pirfenidone for the treatment of idiopathic pulmonary fibrosis: therapeutic potential prompts further investigation.Potential treatment for vocal fold scar with pirfenidone.A single dose of pirfenidone attenuates neuronal loss and reduces lipid peroxidation after kainic acid-induced excitotoxicity in the pubescent rat hippocampus.The effects of pirfenidone in patients with an acute exacerbation of interstitial pneumonia.
P2860
Q23911250-2A06D9DF-A6E6-46A1-B82E-984FE0C6A976Q26738458-A19FC272-457D-4A56-BEC0-B34A17E07165Q26783169-3ECE334D-1561-44A6-AAC5-D2DB82D690BAQ26797272-0C99205E-E01D-41AA-953F-F28076DF44D9Q26849378-6D9B2621-42E4-476B-A069-B6DE860AF17AQ33577258-2320735B-F03C-4029-922B-7033889D995FQ34116805-B09E9571-928C-4553-B25E-C2BC5EC87F3CQ34123201-4A0DAE8F-729B-4FC8-A505-4E07C2904533Q34554406-2289EC64-A76E-4FB1-AD97-3AED3839E70CQ34574174-755EBDB8-739A-4949-BFBB-12C7BF56F9B1Q34623073-2241D94D-3C63-433F-90E2-66CB88B4B3DFQ34680788-A434ABD0-102A-45CD-88E7-86461ADF4C9FQ35177613-3BAB4BAE-DA34-412A-8981-E2EC661726CEQ35551942-B138A6EB-C3D3-4C99-998A-F9C7347831F8Q36265743-15F6D10D-C71D-4733-9858-4E8AE9C0AE2FQ36302828-80EF8109-DDFD-48CA-B22B-E3A6CFAA2F6DQ36440438-827B431F-1625-4A49-9EB2-8C655E309305Q36650779-9941F258-899D-4B31-BE3F-6F5085ECE46BQ36847599-8A6D6B32-F6A1-426A-8967-F2034C9EF4AFQ37297659-97D077F1-5CCB-4AD5-82B1-0BFD807B09C1Q37443271-DEE081BA-0350-4898-9317-89CDD295A0B8Q37929163-8799CFD3-F5B7-42CA-9F17-0E0707508524Q38325422-B03F501F-3F3D-4BBB-973F-6F508F925CB1Q38932342-E46DFABF-6FFF-467B-99DF-E9D10DB78EA8Q39165575-5AE06094-1B33-4D4E-915D-999157CD0CAEQ41499477-C3A4B87E-B581-4CAA-B4B3-AFD5082E69E7Q41910552-38EEDBA8-CF87-4F56-B936-F30346717B1DQ42651835-0D5FBB52-A1D3-41C1-BE17-50F134773124Q44169303-375787BA-6591-4CC5-A36F-81CBDAD4EB54Q44482611-ADEC694B-6B4F-4EAD-B57B-C47973D1A532Q45161152-9522E13A-5626-434E-9734-53191DA60923Q46478654-825AA5A9-A213-4365-B8B5-5F624EB737DCQ46779228-1A5FBAA8-C0DF-4BB5-BF64-B3636F85B5C3Q48241454-D7086996-A2DB-4510-AD51-1CE12E9865DCQ48922422-D7E7BCD3-66B8-4123-B638-C07D59C5552FQ54697968-B57B508C-BC1B-4B94-9C64-CC8CD4F8A928
P2860
Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Pirfenidone inhibits NADPH-dep ...... d scavenges hydroxyl radicals.
@en
Pirfenidone inhibits NADPH-dep ...... d scavenges hydroxyl radicals.
@nl
type
label
Pirfenidone inhibits NADPH-dep ...... d scavenges hydroxyl radicals.
@en
Pirfenidone inhibits NADPH-dep ...... d scavenges hydroxyl radicals.
@nl
prefLabel
Pirfenidone inhibits NADPH-dep ...... d scavenges hydroxyl radicals.
@en
Pirfenidone inhibits NADPH-dep ...... d scavenges hydroxyl radicals.
@nl
P356
P1476
Pirfenidone inhibits NADPH-dep ...... d scavenges hydroxyl radicals.
@en
P2093
P2888
P304
P356
10.1023/A:1007023532508
P577
2000-01-01T00:00:00Z
P6179
1043013992